Abstract
Three antigenic variants of foot-and-mouth disease virus, type A, strain 119, were demonstrated in Ouchterlony analyses utilizing serum collected from guinea pigs 7 days postinfection (DPI). Such antisera contain antibodies of the 19S class. Guinea pig antisera that contained antibodies of the 7S class were unable to distinguish between the antigenic variants. Similarly, 19S antibody was able to demonstrate antigenic differences in trypsin- and chymotrypsin-treated viruses that were not detected by 7S antibody-containing antisera. One of the antigenic variants of virus is apparently the wild type and is tentatively considered to have two antigenic determinant groupings termed the a- and b-sites (140S-ab). The 140S-ab variant was the sole or predominant antigenic type produced in guinea pigs and in large plaque-forming- and tissue culture-low passage sources of the virus. Another antigenic variant appears to possess only the b-site (140S-b) and was the major constituent in tissue culture-high passage virus preparations. The third variant, a small plaque former, was also devoid of the a-site and contains an antigenic determinant that is related to, but not identical with, the b-site. This variant appears to be a minor constituent of tissue culture-high passage virus. 7-DPI serum could be absorbed with a suitable concentration of tissue culture-high passage virus to remove antibody reactive with the b-determinant site. This absorbed serum still precipitated 140S-ab virus by virtue of still containing antibody reactive with the a-determinant site; however, the neutralizing activity was eliminated. This suggests that the b-site is critical with respect to neutralization while the a-site is noncritical.
Full Text
The Full Text of this article is available as a PDF (1.1 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BACHRACH H. L., TRAUTMAN R., BREESE S. S., Jr CHEMICAL PHYSICAL PROPERTIES OF VIRTUALLY PURE FOOT-AND-MOUTH DISEASE VIRUS. Am J Vet Res. 1964 Mar;25:333–342. [PubMed] [Google Scholar]
- BENACERRAF B., OVARY Z., BLOCH K. J., FRANKLIN E. C. Properties of guinea pig 7S antibodies. I. Electrophoretic separation of two types of guinea pig 7S antibodies. J Exp Med. 1963 Jun 1;117:937–949. doi: 10.1084/jem.117.6.937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BREESE S. S., Jr, TRAUTMAN R., BACHRACH H. L. Analysis by electron microscopy and infectivity of foot-and mouth disease virus in moving-boundary and zone ultracentrifugation. Arch Biochem Biophys. 1960 Mar;87:1–8. doi: 10.1016/0003-9861(60)90115-6. [DOI] [PubMed] [Google Scholar]
- BROWN F., CARTWRIGHT B., NEWMAN J. F. FURTHER STUDIES OF THE EARLY ANTIBODY IN THE SEA OF CATTLE AND GUINEA PIGS INFECTED WITH FOOT-AND-MOUTH DISEASE VIRUS. J Immunol. 1964 Sep;93:397–402. [PubMed] [Google Scholar]
- BROWN F., HYSLOP N. S., CRICK J., MORROW A. W. THE USE OF ACETYLETHYLENEIMINE IN THE PRODUCTION OF INACTIVATED FOOT-AND-MOUTH DISEASE VACCINES. J Hyg (Lond) 1963 Sep;61:337–344. doi: 10.1017/s0022172400039620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- COWAN K. M., TRAUTMAN R. ANTIBODIES PRODUCED BY GUINEA PIGS INFECTED WITH FOOT-AND-MOUTH DISEASE VIRUS. J Immunol. 1965 Jun;94:858–867. [PubMed] [Google Scholar]
- Cowan K. M. Effect of Merthiolate on agar gel diffusion precipitin reactions with foot-and-mouth disease virus. J Immunol. 1966 Nov;97(5):647–653. [PubMed] [Google Scholar]
- Cowan K. M., Graves J. H. A third antigenic component associated with foot-and-mouth disease infection. Virology. 1966 Nov;30(3):528–540. doi: 10.1016/0042-6822(66)90128-0. [DOI] [PubMed] [Google Scholar]
- Cowan K. M., Gravex J. H. Immunochemical studies of foot-and-mouth disease. 3. Acridine orange staining of agar gel precipitin reactions. Virology. 1968 Mar;34(3):544–548. [PubMed] [Google Scholar]
- Cowan K. M., Trautman R. Immunochemical studies of foot and mouth disease. I. Complement fixation reactions with isolated antigenic components. J Immunol. 1967 Oct;99(4):729–736. [PubMed] [Google Scholar]
- Graves J. H., McKercher P. D., Farris H. E., Jr, Cowan K. M. Early response of cattle and swine to inactivated foot-and-mouth disease vaccine. Res Vet Sci. 1968 Jan;9(1):35–40. [PubMed] [Google Scholar]
- MACPHERSON I., STOKER M. Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence. Virology. 1962 Feb;16:147–151. doi: 10.1016/0042-6822(62)90290-8. [DOI] [PubMed] [Google Scholar]
- POLATNICK J., BACHRACH H. L. PRODUCTION AND PURIFICATION OF MILLIGRAM AMOUNTS OF FOOT-AND-MOUTH DISEASE VIRUS FROM BABY HAMSTER KIDNEY CELL CULTURES. Appl Microbiol. 1964 Jul;12:368–373. doi: 10.1128/am.12.4.368-373.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SCHEIDEGGER J. J. Une micro-méthode de l'immuno-electrophorèse. Int Arch Allergy Appl Immunol. 1955;7(2):103–110. [PubMed] [Google Scholar]
- TRAUTMAN R., BREESE S. S., Jr Isodensity ultracentrifugation of foot-and-mouth disease virus in caesium chloride. J Gen Microbiol. 1962 Feb;27:231–239. doi: 10.1099/00221287-27-2-231. [DOI] [PubMed] [Google Scholar]
- Vande Woude G. F., Bachrach H. L. Evidence for a single structural polypeptide in foot-and-mouth disease virus. Arch Gesamte Virusforsch. 1968;23(4):353–361. doi: 10.1007/BF01242131. [DOI] [PubMed] [Google Scholar]
- Wild T. F., Brown F. Nature of the inactivating action of trypsin on foot-and-mouth disease virus. J Gen Virol. 1967 Apr;1(2):247–250. doi: 10.1099/0022-1317-1-2-247. [DOI] [PubMed] [Google Scholar]